NasdaqGS:BIIBBiotechs
Will Major North Carolina Expansion Change Biogen's (BIIB) Narrative?
Earlier this month, Biogen announced it will invest an additional US$2 billion to expand its manufacturing footprint in North Carolina's Research Triangle Park, bringing its total investment in the region to approximately US$10 billion and supporting advanced production capabilities for its late-stage pipeline.
This expansion not only increases Biogen's production capacity but also underscores the company's dedication to scaling up its clinical pipeline, particularly in innovative genetic...